Bitcoin.com
KalshiScience and Technology

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

COMP360 Psilocybin for Treatment-Resistant Depression

Ends Jan 1, 2027

Bet Now
Disclosure

18+ only. Event contracts carry significant risk and are not suitable for everyone, you can lose the entire amount you commit. Not available in all jurisdictions; restrictions and eligibility requirements apply.

Probability

  • Before Jan 1, 20274.2K VOL.
    Yes 30%No 70%
    30¢
  • Before Mar 1, 20272K VOL.
    Yes 53%No 47%
    53¢
  • Before July 20278.6K VOL.
    Yes 86%No 14%
    86¢
  • Before October 20272.3K VOL.
    Yes 90%No 10%
    90¢
  • Before 20281.1K VOL.
    Yes 92%No 8%
    92¢

Rules Summary

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

Timeline and Payout

Opened
May 16, 2026, 2:30 AM
Closes
Jan 1, 2027, 4:59 AM
Pays out
0.5 hours after close

Series KXFDAAPPROVALDATECMPS · Event KXFDAAPPROVALDATECMPS-360 · Market KXFDAAPPROVALDATECMPS-360-27JAN01